Microbix Biosystems (TSE:MBX) Stock Price Crosses Below 200-Day Moving Average of $0.35

Microbix Biosystems Inc. (TSE:MBX)’s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of C$0.35 and traded as low as C$0.33. Microbix Biosystems shares last traded at C$0.33, with a volume of 60,286 shares changing hands.

Microbix Biosystems Price Performance

The company has a quick ratio of 5.57, a current ratio of 8.53 and a debt-to-equity ratio of 24.53. The firm has a fifty day moving average price of C$0.32 and a two-hundred day moving average price of C$0.35. The stock has a market capitalization of C$45.35 million, a P/E ratio of 11.00 and a beta of 0.25.

Microbix Biosystems Company Profile

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.